nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.745	1	CbGaD
Ceftriaxone—Hyperkinesia—Montelukast—chronic obstructive pulmonary disease	0.00193	0.00777	CcSEcCtD
Ceftriaxone—Dysgeusia—Roflumilast—chronic obstructive pulmonary disease	0.0019	0.00767	CcSEcCtD
Ceftriaxone—Hypertonia—Salbutamol—chronic obstructive pulmonary disease	0.00187	0.00753	CcSEcCtD
Ceftriaxone—Hyperkinesia—Salbutamol—chronic obstructive pulmonary disease	0.00186	0.00749	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Roflumilast—chronic obstructive pulmonary disease	0.0018	0.00727	CcSEcCtD
Ceftriaxone—Cefdinir—MPO—chronic obstructive pulmonary disease	0.00176	0.265	CrCbGaD
Ceftriaxone—Malaise—Roflumilast—chronic obstructive pulmonary disease	0.00175	0.00707	CcSEcCtD
Ceftriaxone—Lymphopenia—Prednisone—chronic obstructive pulmonary disease	0.00174	0.007	CcSEcCtD
Ceftriaxone—Palpitations—Roflumilast—chronic obstructive pulmonary disease	0.00172	0.00693	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Prednisolone—chronic obstructive pulmonary disease	0.00165	0.00666	CcSEcCtD
Ceftriaxone—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00164	0.00659	CcSEcCtD
Ceftriaxone—Haematuria—Aminophylline—chronic obstructive pulmonary disease	0.00158	0.00638	CcSEcCtD
Ceftriaxone—Infection—Roflumilast—chronic obstructive pulmonary disease	0.00158	0.00635	CcSEcCtD
Ceftriaxone—Renal failure—Tiotropium—chronic obstructive pulmonary disease	0.00154	0.0062	CcSEcCtD
Ceftriaxone—Stomatitis—Tiotropium—chronic obstructive pulmonary disease	0.00152	0.00615	CcSEcCtD
Ceftriaxone—Epistaxis—Tiotropium—chronic obstructive pulmonary disease	0.00148	0.00595	CcSEcCtD
Ceftriaxone—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00586	CcSEcCtD
Ceftriaxone—Aspartate aminotransferase increased—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00583	CcSEcCtD
Ceftriaxone—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00144	0.00583	CcSEcCtD
Ceftriaxone—Abdominal pain upper—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.0057	CcSEcCtD
Ceftriaxone—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.0014	0.00563	CcSEcCtD
Ceftriaxone—Bronchospasm—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00562	CcSEcCtD
Ceftriaxone—Bronchospasm—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00562	CcSEcCtD
Ceftriaxone—Flushing—Aminophylline—chronic obstructive pulmonary disease	0.00138	0.00557	CcSEcCtD
Ceftriaxone—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00137	0.00554	CcSEcCtD
Ceftriaxone—Pancreatitis—Montelukast—chronic obstructive pulmonary disease	0.00136	0.00548	CcSEcCtD
Ceftriaxone—Bronchospasm—Salbutamol—chronic obstructive pulmonary disease	0.00132	0.0053	CcSEcCtD
Ceftriaxone—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00131	0.00527	CcSEcCtD
Ceftriaxone—Cefotetan—ALB—chronic obstructive pulmonary disease	0.0013	0.196	CrCbGaD
Ceftriaxone—Sweating increased—Salbutamol—chronic obstructive pulmonary disease	0.0013	0.00525	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.0013	0.00523	CcSEcCtD
Ceftriaxone—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00126	0.00508	CcSEcCtD
Ceftriaxone—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00125	0.00506	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00123	0.00494	CcSEcCtD
Ceftriaxone—Jaundice—Montelukast—chronic obstructive pulmonary disease	0.00121	0.00486	CcSEcCtD
Ceftriaxone—Haematuria—Arformoterol—chronic obstructive pulmonary disease	0.0012	0.00485	CcSEcCtD
Ceftriaxone—Haematuria—Formoterol—chronic obstructive pulmonary disease	0.0012	0.00485	CcSEcCtD
Ceftriaxone—Dermatitis atopic—Prednisone—chronic obstructive pulmonary disease	0.0012	0.00484	CcSEcCtD
Ceftriaxone—Agitation—Aminophylline—chronic obstructive pulmonary disease	0.00119	0.0048	CcSEcCtD
Ceftriaxone—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00117	0.00471	CcSEcCtD
Ceftriaxone—Epistaxis—Montelukast—chronic obstructive pulmonary disease	0.00117	0.0047	CcSEcCtD
Ceftriaxone—Jaundice—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00468	CcSEcCtD
Ceftriaxone—Stomatitis—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00468	CcSEcCtD
Ceftriaxone—Fungal infection—Prednisone—chronic obstructive pulmonary disease	0.00115	0.00464	CcSEcCtD
Ceftriaxone—Palpitations—Aminophylline—chronic obstructive pulmonary disease	0.00115	0.00462	CcSEcCtD
Ceftriaxone—Haematuria—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00458	CcSEcCtD
Ceftriaxone—Cefpiramide—ALB—chronic obstructive pulmonary disease	0.00113	0.171	CrCbGaD
Ceftriaxone—Epistaxis—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00453	CcSEcCtD
Ceftriaxone—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.00112	0.00453	CcSEcCtD
Ceftriaxone—Glycosuria—Prednisone—chronic obstructive pulmonary disease	0.0011	0.00442	CcSEcCtD
Ceftriaxone—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.00109	0.00438	CcSEcCtD
Ceftriaxone—Palpitations—Tiotropium—chronic obstructive pulmonary disease	0.00108	0.00436	CcSEcCtD
Ceftriaxone—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00434	CcSEcCtD
Ceftriaxone—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00431	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.00106	0.00427	CcSEcCtD
Ceftriaxone—Infection—Aminophylline—chronic obstructive pulmonary disease	0.00105	0.00424	CcSEcCtD
Ceftriaxone—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00423	CcSEcCtD
Ceftriaxone—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00105	0.00423	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.00102	0.00413	CcSEcCtD
Ceftriaxone—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00101	0.00407	CcSEcCtD
Ceftriaxone—Rash—Roflumilast—chronic obstructive pulmonary disease	0.001	0.00403	CcSEcCtD
Ceftriaxone—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000999	0.00403	CcSEcCtD
Ceftriaxone—Oedema—Tiotropium—chronic obstructive pulmonary disease	0.000998	0.00402	CcSEcCtD
Ceftriaxone—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000994	0.00401	CcSEcCtD
Ceftriaxone—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.004	CcSEcCtD
Ceftriaxone—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000991	0.004	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—chronic obstructive pulmonary disease	0.000987	0.149	CrCbGaD
Ceftriaxone—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000966	0.0039	CcSEcCtD
Ceftriaxone—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000966	0.0039	CcSEcCtD
Ceftriaxone—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00096	0.00387	CcSEcCtD
Ceftriaxone—Leukocytosis—Prednisone—chronic obstructive pulmonary disease	0.000945	0.00381	CcSEcCtD
Ceftriaxone—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000942	0.0038	CcSEcCtD
Ceftriaxone—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000931	0.00375	CcSEcCtD
Ceftriaxone—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000918	0.0037	CcSEcCtD
Ceftriaxone—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000917	0.0037	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000915	0.00369	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000915	0.00369	CcSEcCtD
Ceftriaxone—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000912	0.00368	CcSEcCtD
Ceftriaxone—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000907	0.00366	CcSEcCtD
Ceftriaxone—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000907	0.00366	CcSEcCtD
Ceftriaxone—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000896	0.00361	CcSEcCtD
Ceftriaxone—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00089	0.00359	CcSEcCtD
Ceftriaxone—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00089	0.00359	CcSEcCtD
Ceftriaxone—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000888	0.00358	CcSEcCtD
Ceftriaxone—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.000878	0.00354	CcSEcCtD
Ceftriaxone—Palpitations—Formoterol—chronic obstructive pulmonary disease	0.000872	0.00352	CcSEcCtD
Ceftriaxone—Palpitations—Arformoterol—chronic obstructive pulmonary disease	0.000872	0.00352	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000865	0.00349	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000864	0.00348	CcSEcCtD
Ceftriaxone—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000856	0.00345	CcSEcCtD
Ceftriaxone—Palpitations—Montelukast—chronic obstructive pulmonary disease	0.000854	0.00344	CcSEcCtD
Ceftriaxone—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00084	0.00339	CcSEcCtD
Ceftriaxone—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00084	0.00339	CcSEcCtD
Ceftriaxone—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000837	0.00338	CcSEcCtD
Ceftriaxone—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000836	0.00337	CcSEcCtD
Ceftriaxone—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000836	0.00337	CcSEcCtD
Ceftriaxone—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00083	0.00335	CcSEcCtD
Ceftriaxone—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00083	0.00335	CcSEcCtD
Ceftriaxone—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.000823	0.00332	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000816	0.00329	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000805	0.00325	CcSEcCtD
Ceftriaxone—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.000805	0.00325	CcSEcCtD
Ceftriaxone—Oedema—Formoterol—chronic obstructive pulmonary disease	0.000805	0.00325	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000805	0.00325	CcSEcCtD
Ceftriaxone—Infection—Formoterol—chronic obstructive pulmonary disease	0.0008	0.00323	CcSEcCtD
Ceftriaxone—Infection—Arformoterol—chronic obstructive pulmonary disease	0.0008	0.00323	CcSEcCtD
Ceftriaxone—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000793	0.0032	CcSEcCtD
Ceftriaxone—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000789	0.00318	CcSEcCtD
Ceftriaxone—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000789	0.00318	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000789	0.00318	CcSEcCtD
Ceftriaxone—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000784	0.00316	CcSEcCtD
Ceftriaxone—Infection—Montelukast—chronic obstructive pulmonary disease	0.000784	0.00316	CcSEcCtD
Ceftriaxone—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000779	0.00314	CcSEcCtD
Ceftriaxone—Hyperkinesia—Prednisone—chronic obstructive pulmonary disease	0.000775	0.00312	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000772	0.00311	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00307	CcSEcCtD
Ceftriaxone—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00076	0.00307	CcSEcCtD
Ceftriaxone—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000755	0.00305	CcSEcCtD
Ceftriaxone—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000752	0.00303	CcSEcCtD
Ceftriaxone—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000748	0.00302	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000747	0.00301	CcSEcCtD
Ceftriaxone—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.000745	0.003	CcSEcCtD
Ceftriaxone—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000735	0.00296	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000735	0.00296	CcSEcCtD
Ceftriaxone—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000724	0.00292	CcSEcCtD
Ceftriaxone—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000709	0.00286	CcSEcCtD
Ceftriaxone—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000709	0.00286	CcSEcCtD
Ceftriaxone—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000708	0.00286	CcSEcCtD
Ceftriaxone—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000706	0.00285	CcSEcCtD
Ceftriaxone—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.0007	0.00282	CcSEcCtD
Ceftriaxone—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000694	0.0028	CcSEcCtD
Ceftriaxone—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000689	0.00278	CcSEcCtD
Ceftriaxone—Pain—Formoterol—chronic obstructive pulmonary disease	0.000689	0.00278	CcSEcCtD
Ceftriaxone—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00275	CcSEcCtD
Ceftriaxone—Pain—Montelukast—chronic obstructive pulmonary disease	0.000674	0.00272	CcSEcCtD
Ceftriaxone—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000673	0.00271	CcSEcCtD
Ceftriaxone—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000669	0.0027	CcSEcCtD
Ceftriaxone—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000667	0.00269	CcSEcCtD
Ceftriaxone—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000666	0.00269	CcSEcCtD
Ceftriaxone—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000664	0.00268	CcSEcCtD
Ceftriaxone—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000664	0.00268	CcSEcCtD
Ceftriaxone—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000663	0.00267	CcSEcCtD
Ceftriaxone—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00066	0.00266	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000658	0.00265	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000658	0.00265	CcSEcCtD
Ceftriaxone—Pain—Salbutamol—chronic obstructive pulmonary disease	0.00065	0.00262	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000645	0.0026	CcSEcCtD
Ceftriaxone—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00064	0.00258	CcSEcCtD
Ceftriaxone—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00064	0.00258	CcSEcCtD
Ceftriaxone—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000637	0.00257	CcSEcCtD
Ceftriaxone—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000637	0.00257	CcSEcCtD
Ceftriaxone—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000637	0.00257	CcSEcCtD
Ceftriaxone—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000637	0.00257	CcSEcCtD
Ceftriaxone—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000634	0.00256	CcSEcCtD
Ceftriaxone—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000629	0.00254	CcSEcCtD
Ceftriaxone—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000628	0.00253	CcSEcCtD
Ceftriaxone—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000628	0.00253	CcSEcCtD
Ceftriaxone—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000627	0.00253	CcSEcCtD
Ceftriaxone—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000627	0.00253	CcSEcCtD
Ceftriaxone—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000625	0.00252	CcSEcCtD
Ceftriaxone—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000623	0.00251	CcSEcCtD
Ceftriaxone—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000623	0.00251	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000622	0.00251	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.000617	0.00249	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000614	0.00247	CcSEcCtD
Ceftriaxone—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000604	0.00244	CcSEcCtD
Ceftriaxone—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00242	CcSEcCtD
Ceftriaxone—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000601	0.00242	CcSEcCtD
Ceftriaxone—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000593	0.00239	CcSEcCtD
Ceftriaxone—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000593	0.00239	CcSEcCtD
Ceftriaxone—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000593	0.00239	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—chronic obstructive pulmonary disease	0.000582	0.0876	CrCbGaD
Ceftriaxone—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000581	0.00234	CcSEcCtD
Ceftriaxone—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00057	0.0023	CcSEcCtD
Ceftriaxone—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00057	0.0023	CcSEcCtD
Ceftriaxone—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00056	0.00226	CcSEcCtD
Ceftriaxone—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000558	0.00225	CcSEcCtD
Ceftriaxone—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000551	0.00222	CcSEcCtD
Ceftriaxone—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000551	0.00222	CcSEcCtD
Ceftriaxone—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.000546	0.0022	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000543	0.00219	CcSEcCtD
Ceftriaxone—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.00054	0.00218	CcSEcCtD
Ceftriaxone—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000538	0.00217	CcSEcCtD
Ceftriaxone—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000532	0.00215	CcSEcCtD
Ceftriaxone—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000532	0.00215	CcSEcCtD
Ceftriaxone—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000522	0.0021	CcSEcCtD
Ceftriaxone—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000521	0.0021	CcSEcCtD
Ceftriaxone—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.00052	0.0021	CcSEcCtD
Ceftriaxone—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000512	0.00206	CcSEcCtD
Ceftriaxone—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000512	0.00206	CcSEcCtD
Ceftriaxone—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00205	CcSEcCtD
Ceftriaxone—Rash—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00205	CcSEcCtD
Ceftriaxone—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000507	0.00204	CcSEcCtD
Ceftriaxone—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000507	0.00204	CcSEcCtD
Ceftriaxone—Headache—Formoterol—chronic obstructive pulmonary disease	0.000504	0.00203	CcSEcCtD
Ceftriaxone—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.00203	CcSEcCtD
Ceftriaxone—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00203	CcSEcCtD
Ceftriaxone—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000501	0.00202	CcSEcCtD
Ceftriaxone—Rash—Montelukast—chronic obstructive pulmonary disease	0.000497	0.002	CcSEcCtD
Ceftriaxone—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000497	0.002	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000496	0.002	CcSEcCtD
Ceftriaxone—Headache—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00199	CcSEcCtD
Ceftriaxone—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000483	0.00195	CcSEcCtD
Ceftriaxone—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000482	0.00194	CcSEcCtD
Ceftriaxone—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00193	CcSEcCtD
Ceftriaxone—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000479	0.00193	CcSEcCtD
Ceftriaxone—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000478	0.00193	CcSEcCtD
Ceftriaxone—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000478	0.00193	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—chronic obstructive pulmonary disease	0.000478	0.072	CrCbGaD
Ceftriaxone—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00192	CcSEcCtD
Ceftriaxone—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000468	0.00189	CcSEcCtD
Ceftriaxone—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000463	0.00187	CcSEcCtD
Ceftriaxone—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00182	CcSEcCtD
Ceftriaxone—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000449	0.00181	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00181	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000446	0.0018	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00176	CcSEcCtD
Ceftriaxone—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000436	0.00176	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000422	0.0017	CcSEcCtD
Ceftriaxone—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000414	0.00167	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—chronic obstructive pulmonary disease	0.000397	0.0598	CrCbGaD
Ceftriaxone—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.00158	CcSEcCtD
Ceftriaxone—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000373	0.0015	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.00036	0.00145	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000359	0.00145	CcSEcCtD
Ceftriaxone—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000359	0.00145	CcSEcCtD
Ceftriaxone—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000357	0.00144	CcSEcCtD
Ceftriaxone—Malaise—Prednisone—chronic obstructive pulmonary disease	0.00035	0.00141	CcSEcCtD
Ceftriaxone—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000346	0.0014	CcSEcCtD
Ceftriaxone—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000336	0.00136	CcSEcCtD
Ceftriaxone—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000327	0.00132	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000321	0.0013	CcSEcCtD
Ceftriaxone—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00128	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000317	0.00128	CcSEcCtD
Ceftriaxone—Infection—Prednisone—chronic obstructive pulmonary disease	0.000315	0.00127	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000306	0.00124	CcSEcCtD
Ceftriaxone—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000288	0.00116	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000285	0.00115	CcSEcCtD
Ceftriaxone—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000279	0.00112	CcSEcCtD
Ceftriaxone—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00111	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000275	0.00111	CcSEcCtD
Ceftriaxone—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.0011	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000261	0.00105	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000259	0.00104	CcSEcCtD
Ceftriaxone—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.00104	CcSEcCtD
Ceftriaxone—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00101	CcSEcCtD
Ceftriaxone—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00101	CcSEcCtD
Ceftriaxone—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.00025	0.00101	CcSEcCtD
Ceftriaxone—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000233	0.000941	CcSEcCtD
Ceftriaxone—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000224	0.000904	CcSEcCtD
Ceftriaxone—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000874	CcSEcCtD
Ceftriaxone—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000845	CcSEcCtD
Ceftriaxone—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000201	0.000812	CcSEcCtD
Ceftriaxone—Rash—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000806	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.0002	0.000805	CcSEcCtD
Ceftriaxone—Headache—Prednisone—chronic obstructive pulmonary disease	0.000199	0.0008	CcSEcCtD
Ceftriaxone—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000759	CcSEcCtD
